Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Disease area: Airway diseases

Abstract

In recent years doctors from all around the world paying the high attention to the treatment of bronchial asthma in gestation during pregnancy. The main aim of this research is to get a better knowledge how the DCR of bronchial asthma in gestation during pregnancy influence the course of pregnancy, the fetus and the newborns. The research involves the explorations, descriptions of the bronchial asthmas clinical features, pregnancy and birth outcomes, newborns health (290 women who suffer from bronchial asthma were tested). The information was received through Asthma Control Test. Research results:
1 62.5% of the patients had have uncontrolled asthma;
2 37.5% of the patients had have controlled asthma;
The 1st group of the patients (51.7%) took control drugs (28% - cromones; 63,3% - inhalation corticosteroids; 8,7% – prednisolonum), the 2nd group of the patients (31%) because of the pregnancy took emergency drugs. The patients from the 1st group had had better respiratory function than the patients from the 2nd group (p<0.05). The patients from the 2nd group had had the complications of pregnancy like the threat of termination of pregnancy (2 occasions), early pregnancy toxicosis (2.9 occasions),the gestosis (2 occasions), chronic fetoplacental insufficiency (1.4 occasions), chronic prenatal hypoxia (1.3 occasions), cerebral ischemia, prenatal developmental delays, prenatal infection (p<0.05).
To sum up, the optimal asthma control during pregnancy will help in prevention of gestational complications and descendants’ health improvement.

Rating:

Share or cite this content

Citations should be made in the following way:
T. Luchnikova, O. Prikhodko, Y. Landyshev, A. Babtseva, E. Romantsova, E. Smorodina (Blagoveshchensk, Russian Federation). LATE-BREAKING ABSTRACT: Disease control rate (DRC) of bronchial asthma during pregnancy. Eur Respir J 2013; 42: Suppl. 57, 4156

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: The analysis of the severe asthma prevalence rate in China Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 Priorities for asthma R&D in Europe: A systematic approach Source: International Congress 2016 – Asthma points to ponder Year: 2016 Childhood obesity in relation to poor asthma control and exacerbations Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 LATE-BREAKING ABSTRACT: Using eosinophilic phenotype to characterize asthma control. Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 Epoxy and delayed asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 What is important to people with asthma: Maximising research impact? Source: International Congress 2015 – Any news from the asthma field? Year: 2015 LATE-BREAKING ABSTRACT: Anti-interleukin-5 in severe asthma: Blood eosinophilia predicts lung function improvement Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 A case diagnoed ACOS with omelizumab treatment Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Overlap phenotypes of asthma in adults: Obesity and atopy Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 COPD and the asthma-COPD-overlap-syndrome Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Psychophysiology of depression in bronchial asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 Smoking in severe asthma Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014